Pioneer Municipal High Inc (MAV) to Issue Monthly Dividend of $0.04 on September 30th

Share on StockTwits

Pioneer Municipal High Inc (NYSE:MAV) announced a monthly dividend on Thursday, September 5th, NASDAQ reports. Stockholders of record on Wednesday, September 18th will be given a dividend of 0.038 per share on Monday, September 30th. This represents a $0.46 annualized dividend and a dividend yield of 4.27%. The ex-dividend date is Tuesday, September 17th.

Pioneer Municipal High has decreased its dividend by an average of 14.8% per year over the last three years.

MAV stock opened at $10.68 on Friday. Pioneer Municipal High has a twelve month low of $10.00 and a twelve month high of $11.19. The business has a 50 day simple moving average of $11.03 and a 200-day simple moving average of $10.77.

Separately, Royal Bank of Canada reissued a “buy” rating and issued a $8.50 price objective on shares of Pioneer Municipal High in a report on Thursday, August 8th.

About Pioneer Municipal High

Pioneer Municipal High Income Advantage Trust is a closed ended fixed income mutual fund launched and managed by Pioneer Investment Management, Inc The fund invests in the fixed income markets of the United States. It invests primarily in municipal bonds. The fund benchmarks the performance of its portfolio against the Barclays Capital High Yield Municipal Bond Index and the Barclays Capital Municipal Bond Index.

Featured Story: Trading signals using Bollinger bands

Dividend History for Pioneer Municipal High (NYSE:MAV)

Receive News & Ratings for Pioneer Municipal High Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pioneer Municipal High and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Lawson Products  Cut to Hold at Zacks Investment Research
Lawson Products Cut to Hold at Zacks Investment Research
USA Technologies  Stock Rating Reaffirmed by William Blair
USA Technologies Stock Rating Reaffirmed by William Blair
Consort Medical  Upgraded by Shore Capital to Buy
Consort Medical Upgraded by Shore Capital to Buy
Axsome Therapeutics  Raised to “Hold” at BidaskClub
Axsome Therapeutics Raised to “Hold” at BidaskClub
Macquarie Begins Coverage on UBISOFT ENTMT S/ADR
Macquarie Begins Coverage on UBISOFT ENTMT S/ADR
Nephros  Upgraded to Buy by Zacks Investment Research
Nephros Upgraded to Buy by Zacks Investment Research


© 2006-2019 Ticker Report